Stevens - Johnson Syndrome Induced by Sorafenib for Hepatocellular Carcinoma
Journal Title: International Journal of Clinical Dermatology & Research (IJCDR) - Year 2016, Vol 4, Issue 2
Abstract
Background: Sorafenib is a new therapeutic agent being used in hepatocellular carcinoma, renal cell carcinoma and malignant melanoma. The most frequently seen cutaneous side effects due to sorafenib are erythema, exfoliative dermatitis, acne vulgaris and hand-foot skin reaction. Erythema multiforme, stevens-johnson syndrome are rare side effects of sorafenib. Observation: We present a 34-years-old woman with stevens-Johnson syndrome induced by sorafenib for hepatocellular carcinoma. Conclusion: Patients treated with sorafenib for HCC should be monitored closely with a multidisciplinary approach, and if SJS is diagnosed, these patients cannot be given sorafenib again.
Authors and Affiliations
Chakiri Radia
Keywords
Related Articles
- EP ID EP211290
- DOI 10.19070/2332-2977-160001
- Views 115
- Downloads 0
Chronic Cutaneous Blastomycosis
We present an interesting case of chronic cutaneous blastomycosis occurring in a 71-year-old veterinarian diagnosed by morphologic examination, highlighting the clinical presentation, morphologic appearance, and treatmen...
The Association Between Pressure Ulcer Development And Patient Comorbidities In Varied Care Settings: A Review Of The Literature
Pressure ulcers can be described as localized injury to the skin which can develop in the patients placed in various types of care setting. The comorbidities, or underlying diseases of the patients, are thought to be str...
Melanoma Immunotherapy: Promising against Cancer Cells Growth and for Survival Increase?
Melanoma Immunotherapy: Promising against Cancer Cells Growth and for Survival Increase?
Unilateral Nevoid Hyperkeratosis of the Nipple and Areola Treated Successfully With Carbon Dioxide Laser
Nevoid hyperkeratosis of the nipple and areola (NHNA), is a rare benign condition characterized by papular warty excrescences on the nipple, the areola or both. We report a female patient with this rare condition appeare...
Stevens - Johnson Syndrome Induced by Sorafenib for Hepatocellular Carcinoma
Background: Sorafenib is a new therapeutic agent being used in hepatocellular carcinoma, renal cell carcinoma and malignant melanoma. The most frequently seen cutaneous side effects due to sorafenib are erythema, exfolia...